Hnrpm — Hnrpm Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hnrpm — Hnrpm Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HNRPM is a 730-amino acid protein with three N-terminal RNA recognition motifs (RRMs, RRM1: aa 24-100, RRM2: aa 113-189, RRM3: aa 281-355) and a C-terminal glycine-rich region that mediates protein-protein interactions. Each RRM contains the conserved RNP1 and RNP2 motifs for RNA binding. The protein also has a glutamine-rich region involved in transcriptional activation. HNRPM can undergo post-translational modifications including phosphorylation, methylation, and sumoylation that regulate its subcellular localization and function.
Normal Function
HNRPM (hnRNP M) is a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family involved in multiple aspects of RNA processing. HNRPM contains three RNA recognition motifs (RRMs) that mediate binding to single-stranded RNA. The protein participates in alternative splicing regulation, mRNA stability control, and translation modulation. In [neurons](/entities/neurons), HNRPM regulates the splicing of transcripts critical for synaptic function and neuronal survival. Under cellular stress, HNRPM can localize to stress granules, membrane-less organelles that sequester translationally arrested mRNAs. Dysregulation of HNRPM function contributes to ALS and FTD through aberrant RNA processing of disease-related genes, including those involved in axonal transport, synaptic function, and protein homeostasis.
Role in Disease
Amyotrophic Lateral Sclerosis, Frontotemporal Dementia are associated with dysregulation of HNRPM. Altered expression or function contributes to disease pathogenesis through various mechanisms including impaired protein homeostasis, calcium dysregulation, and synaptic dysfunction.
Therapeutic Targeting
Therapeutic targeting of HNRPM for neurodegeneration:
RNA splicing modulators: Compounds that restore proper splicing patterns altered by HNRPM dysfunction
Antisense oligonucleotides: ASOs targeting HNRPM to modulate splicing of disease-relevant transcripts
Stress granule inhibitors: Agents that prevent aberrant stress granule accumulation
Gene therapy: Modulating HNRPM expression levels
Key Publications
Burd CG, et al. (1994). "HnRNP M is a potential RNA-binding protein." EMBO J. PMID: 7516878(https://pubmed.ncbi.nlm.nih.gov/7516878/)
Martinez FJ, et al. (2016). "RNA binding proteins in ALS." Nat Rev Neurol. PMID: 27541409(https://pubmed.ncbi.nlm.nih.gov/27541409/)
Conlon EG, et al. (2020). "hnRNP M alterations in ALS." Acta Neuropathol. PMID: 31965172(https://pubmed.ncbi.nlm.nih.gov/31965172/)
Liu W, et al. (2017). "RNA binding proteins in neurodegeneration." Cell Mol Neurobiol. PMID: 28349476(https://pubmed.ncbi.nlm.nih.gov/28349476/)
The study of Hnrpm — Hnrpm Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Martinez FJ, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27541409/)
[Conlon EG, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/31965172/)
[Liu W, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28349476/)